Leadership
Kevin Friedman, PhD
Founder & Chief Executive Officer
Travis Quigley
SVP, Clinical Development
Michael McDonald, PhD, JD
SVP, Legal Affairs & IP
Stacy Gilroy
VP, Talent & Culture
Scott Currence
VP, Clinical Development Operations
Shannon Grande Contrastano, PhD
VP, Preclinical Research
Aditi Soni
VP, Program & Alliance Management
Sarah Tannehill-Gregg, DVM, PhD
VP, Nonclinical Development
Board of Directors
Michael Birnbaum, PhD
Professor of Biological Engineering, MIT
Kevin Friedman, PhD
Founder & Chief Executive Officer
Kristen Hege, MD
Retired SVP, Early Clinical Development, Hematology/Oncology & Cell Therapy Bristol Myers Squibb
Mathai Mammen, MD, PhD
CEO, Parabilis Medicines
Bob More
Managing Director, Alta Partners
Bryan Roberts
Partner, Venrock